Evaluation of peptone glucose fluconazole agar as a selective medium for rapid and enhanced isolation of Aspergillus fumigatus from the respiratory tract of bronchopulmonary aspergillosis patients colonized by Candida albicans.
We have reported earlier that Aspergillus fumigatus is inhibited in vitro by Candida albicans which also interferes in its isolation from sputum experimentally seeded with predetermined graded inocula of the two fungi. It was further shown that this interference was neutralized by employing peptone glucose agar with incorporation of fluconazole which is more inhibitory to C. albicans than to A. fumigatus. This communication embodies the results of evaluation of peptone glucose fluconazole agar (PGFA) as a selective culture medium for rapid and enhanced isolation of A. fumigatus from sputum of patients clinically suspected of aspergillosis with C. albicans colonization in the respiratory tract. Of the 23 sputum specimens and one broncho-alveolar lavage collected from 15 suspected aspergillosis patients, A. fumigatus was isolated from all (100%) on PGFA as against only 19 specimens (79%) that proved to be positive on the control PGA medium (P<0.05). The greater efficacy of PGFA than that of PGA was further evident from the 2-fold higher A. fumigatus mean colony count (8.2+/-1.87) on the former medium than on the latter (3.7+/-1.00), and this difference was found to be statistically significant (P<0.05). Besides, A. fumigatus colonies were macroscopically recognizable within 2-3 days on PGFA at 28 degrees C in strong contrast to 5-7 days required on PGA. Based upon these observations, PGFA is recommended for wider application as a selective medium for rapid and enhanced recovery of A. fumigatus from sputum of patients clinically suspected of aspergillosis with C. albicans colonization in their respiratory tract.
Randhawa
H S
HS
Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India. hsrandh5@yahoo.co.in
Chowdhary
Anuradha
A
Preeti Sinha
K
K
Kowshik
T
T
Vijayan
V K
VK
D000362:Agar; D000935:Antifungal Agents / Q000494:pharmacology*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000382:microbiology*; D001232:Aspergillus fumigatus / Q000254:growth & development / Q000302:isolation & purification*; D002176:Candida albicans / Q000254:growth & development*; D015169:Colony Count, Microbial; D003470:Culture Media / Q000737:chemistry*; D015725:Fluconazole / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008828:Microbiological Techniques; D009172:Mycology / Q000379:methods; D010461:Peptones / Q000378:metabolism; D012137:Respiratory System / Q000382:microbiology*
D000935:Antifungal Agents; D003470:Culture Media; D010461:Peptones; D015725:Fluconazole; D000362:Agar; D005947:Glucose